The DOI matches its Crossref record.
Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial
Open accessAbstract
BACKGROUND: The randomized EORTC 10981-22023 AMAROS trial investigates whether breast cancer patients with a tumor-positive sentinel node biopsy (SNB) are best treated with an axillary lymph node dissection (ALND) or axillary radiotherapy (ART). The aim of the current substudy was to evaluate the identification rate and the nodal involvement. METHODS: The first 2,000 patients participating in the AMAROS trial were evaluated. Associations between the identification rate and technical, patient-, and tumor-related factors were evaluated. The outcome of the SNB procedure and potential further nodal involvement was assessed. RESULTS: In 65 patients, the sentinel node could not be identified. As a result, the sentinel node identification rate was 97% (1,888 of 1,953). Variables affecting the success rate were age, pathological tumor size, histology, year of accrual, and method of detection. The SNB results of 65% of the patients (n = 1,220) were negative and the patients underwent no further axillary treatment. The SNB results were positive in 34% of the patients (n = 647), including macrometastases (n = 409, 63%), micrometastases (n = 161, 25%), and isolated tumor cells (n = 77, 12%). Further nodal involvement in patients with macrometastases, micrometastases, and isolated tumor cells undergoing an ALND was 41, 18, and 18%, respectively. CONCLUSIONS: With a 97% detection rate in this prospective international multicenter study, the SNB procedure is highly effective, especially when the combined method is used. Further nodal involvement in patients with micrometastases and isolated tumor cells in the sentinel node was similar-both were 18%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Donker, M., van Tienhoven, G., Straver, M. E., Meijnen, P., van de Velde, C. J. H., Mansel, R. E., Cataliotti, L., Westenberg, A. H., Klinkenbijl, J. H. G., Orzalesi, L., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70460-7 · Cited by 1,871
Self-citationGalimberti, V., Cole, B. F., Zurrida, S., Viale, G., Luini, A., Veronesi, P., Baratella, P., Chifu, C., Sargenti, M., Intra, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70035-4 · Cited by 1,233
Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review
Ahmed, M., Purushotham, A. D., & Douek, M. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70590-4 · Cited by 358
Brackstone, M., Baldassarre, F. G., Perera, F. E., Cil, T., Chavez Mac Gregor, M., Dayes, I. S., Engel, J., Horton, J. K., King, T. A., Kornecki, A., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00934 · Cited by 271
He, K., Chi, C., Kou, D., Huang, W., Wu, J., Wang, Y., He, L., Ye, J., Mao, Y., Zhang, G.-J., et al. (2016) · Translational Research · doi:10.1016/j.trsl.2016.07.010 · Cited by 46
Metadata
- Authors
- Straver, M. E., Meijnen, P., van Tienhoven, G., van de Velde, C. J. H., Mansel, R. E., Bogaerts, J., Duez, N., Cataliotti, L., Klinkenbijl, J. H. G., Westenberg, H. A., van der Mijle, H., Snoj, M., Hurkmans, C., & Rutgers, E. J. T.
- Venue
- Annals of Surgical Oncology
- Published
- 2010-03-19
- Volume
- 17
- Issue
- 7
- Pages
- 1854-1861
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- OpenAlex
- W2169883647
- Cited by
- 248
- References
- 0
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial. https://app.cochat.ai/papers/10.1245/s10434-010-0945-z
- The paper
- Straver, M. E., Meijnen, P., van Tienhoven, G., van de Velde, C. J. H., Mansel, R. E., Bogaerts, J., Duez, N., Cataliotti, L., Klinkenbijl, J. H. G., Westenberg, H. A., van der Mijle, H., Snoj, M., Hurkmans, C., & Rutgers, E. J. T. (2010). Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-010-0945-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.